Both in Pharmaceuticals
Nuvation Bio vs Supernus Pharmaceuticals
Over the past year NUVB returned −9.3% and SUPN returned −49.5%; their daily moves had a correlation of 0.16.
NUVB −9.3% SUPN −49.5%Growth of $1, one year, split-adjusted
| Metric | NUVB | SUPN |
|---|---|---|
| Price | $4.69 | $28.15 |
| Market cap | $1.65B | $1.64B |
| Today | +2.18% | −32.85% |
| 1 month | −5.3% | −34.2% |
| 6 months | −2.9% | −42.8% |
| Year to date | −47.7% | −43.4% |
| 1 year | −10.2% | — |
| Revenue growth (YoY) | +555.6% | +18.0% |
| Gross margin | 73.0% | 88.1% |
| Net margin | −198.3% | 9.2% |
| P/E (TTM) | — | — |
| Price / sales | 9.7× | 1.9× |
| Net cash | $399.4M | $359.5M |
| Dividend yield | — | 28.88% |
| Volatility (60d) | 51.1% | 86.0% |
| Short % of float | 23.9% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).